We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.37%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$37.4B
AUM Growth
-$234M
(-0.62%)
Cap. Flow
-$832M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
26.05%
Holding
2,051
New
47
Increased
483
Reduced
1,317
Closed
203
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$240M |
| 2 |
Sysco
SYY
|
+$180M |
| 3 |
Synopsys
SNPS
|
+$83.9M |
| 4 |
C.H. Robinson
CHRW
|
+$42.1M |
| 5 |
United Bankshares
UBSI
|
+$38.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$216M |
| 2 |
Apple
AAPL
|
+$189M |
| 3 |
Microsoft
MSFT
|
+$115M |
| 4 |
Meta Platforms (Facebook)
META
|
+$68.7M |
| 5 |
Broadcom
AVGO
|
+$65.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.13% |
| 2 | Consumer Staples | 11.3% |
| 3 | Industrials | 10.65% |
| 4 | Financials | 9.24% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Karyopharm Therapeutics
KPTI
$169M
| $13.2K | ﹤0.01% |
1,011
-346
| -25% | -$5.73K |
|
1827
Energy Vault
NRGV
$544M
| $12.6K | ﹤0.01% |
13,269
-4,530
| -25% | -$5.63K |
|
1828
Douglas Elliman
DOUG
$158M
| $12.6K | ﹤0.01% |
10,860
-3,708
| -25% | -$4.67K |
|
|
MRNS
1829
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $12.5K | ﹤0.01% |
10,724
-2,938
| -22% | -$7.35K |
|
1830
Compass Therapeutics
CMPX
$380M
| $12.2K | ﹤0.01% |
12,223
-4,173
| -25% | -$6.09K |
|
|
KYNB
1831
Kyntra Bio
KYNB
$28.6M
| $11K | ﹤0.01% |
495
-169
| -25% | -$5.22K |
|
1832
American Well
AMWL
$181M
| $11K | ﹤0.01% |
1,687
-576
| -25% | -$5.8K |
|
|
LLAP
1833
DELISTED
Terran Orbital Corporation
LLAP
| $10.7K | ﹤0.01% |
13,028
-4,446
| -25% | -$4.77K |
|
1834
Citius Pharmaceuticals
CTXR
$14.4M
| $10.5K | ﹤0.01% |
721
-246
| -25% | -$4.41K |
|
1835
ESS Tech
GWH
$23.1M
| $10K | ﹤0.01% |
815
-278
| -25% | -$3.13K |
|
1836
X4 Pharmaceuticals
XFOR
$361M
| $9.73K | ﹤0.01% |
559
-191
| -25% | -$6.25K |
|
1837
Seres Therapeutics
MCRB
$49.5M
| $9.54K | ﹤0.01% |
659
-225
| -25% | -$3.75K |
|
1838
Ovid Therapeutics
OVID
$439M
| $9.51K | ﹤0.01% |
12,365
-3,301
| -21% | -$9.19K |
|
|
GRTS
1839
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $7.46K | ﹤0.01% |
12,076
-4,121
| -25% | -$3.48K |
|
|
SGMO
1840
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $7.15K | ﹤0.01% |
19,955
-6,811
| -25% | -$3.68K |
|
|
DNMR
1841
DELISTED
Danimer Scientific, Inc.
DNMR
| $7.09K | ﹤0.01% |
294
-100
| -25% | -$3.11K |
|
1842
Smartbird Inc
BIRD
$21.8M
| $6.49K | ﹤0.01% |
648
-222
| -26% | -$2.71K |
|
1843
LivePerson
LPSN
$19.9M
| $6.1K | ﹤0.01% |
701
-239
| -25% | -$2.29K |
|
1844
Vor Biopharma
VOR
$1.04B
| $5.11K | ﹤0.01% |
+256
| New | +$8.28K |
|
|
VOXX
1845
DELISTED
VOXX International Corporation Class A
VOXX
| $4.96K | ﹤0.01% |
+1,568
| New | +$8.35K |
|
|
BHIL
1846
DELISTED
Benson Hill, Inc.
BHIL
| $3.54K | ﹤0.01% |
663
-226
| -25% | -$1.5K |
|
1847
Zevia
ZVIA
$111M
| $2.29K | ﹤0.01% |
+3,393
| New | +$3.14K |
|
|
AKTS
1848
DELISTED
Akoustis Technologies Inc
AKTS
| $1.68K | ﹤0.01% |
12,765
-4,356
| -25% | -$1.64K |
|
|
AAT
1849
American Assets Trust
AAT
$1.49B
| – | – |
-9,841
| Closed | -$216K |
|
|
AGEN
1850
Agenus
AGEN
$255M
| – | – |
-3,422
| Closed | -$39.7K |
|
Similar funds
ProShare Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, ProShare Advisors held 2,051 positions worth $37.4B, down 0.62% from $37.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
ProShare Advisors's Q2 2024 filing shows 47 new, 483 increased, 1,317 reduced and 203 closed positions. Its largest new stake was KKR & Co: 135,149 shares worth $14.2M. The largest sale was 3M, an estimated $216M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q2 2024 buy was KKR & Co: 135,149 shares worth $14.2M.
- ProShare Advisors added most to Qualcomm in Q2 2024, an estimated $240M increase.
- ProShare Advisors's biggest Q2 2024 reduction was 3M, cutting an estimated $216M.
- ProShare Advisors fully exited Leggett & Platt in Q2 2024, selling an estimated $24.6M.
- ProShare Advisors's ten largest holdings make up 26% of its $37.4B portfolio in Q2 2024.
- ProShare Advisors opened 47 new positions and closed 203 in Q2 2024.
- ProShare Advisors's portfolio value fell 0.62% quarter-over-quarter to $37.4B.
Based on ProShare Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.